Kraig Biocraft Laboratories, Inc. (KBLB) Stock

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. Its primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. The company’s products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; military and police for its ballistic protection; and geotextiles, safe and protective clothing, textiles used in transportation and buildings, and functional and sportive textiles. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Kraig Biocraft Laboratories, Inc. is headquartered in US.

Kraig Biocraft Laboratories, Inc. (KBLB) stock trades at $0.09 with a market capitalization of $100.17M. The stock is valued at a price-to-earnings (P/E) ratio of -24.32, price-to-book of -13.90, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.07 and $0.16, and currently trades 43.8% below its 52-week high.

On profitability, Kraig Biocraft Laboratories, Inc. generates a return on equity (ROE) of 50.38% — well above the market average, a sign of a high-quality business, return on capital employed of 52.04%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.kraiglabs.com